Dr. William G Wierda, MD, PhD
Claim this profileM D Anderson Cancer Center
Studies Lymphoma
Studies Cancer
3 reported clinical trials
6 drugs studied
Area of expertise
1Lymphoma
del(17p) positive
IGHV negative
TP53 positive
2Cancer
del(17p) positive
IGHV negative
TP53 positive
Affiliated Hospitals
Clinical Trials William G Wierda, MD, PhD is currently running
Acalabrutinib + Venetoclax ± Obinutuzumab
for Chronic Lymphocytic Leukemia
This phase II trial studies how well acalabrutinib and venetoclax with or without early obinutuzumab work for the treatment of chronic lymphocytic leukemia or small lymphocytic lymphoma that is high risk, has come back (recurrent), or does not respond to treatment (refractory). Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Venetoclax may stop the growth cancer cells by blocking BCL-2 protein needed for cell growth. Immunotherapy with monoclonal antibodies, such as obinutuzumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving acalabrutinib and venetoclax together with early obinutuzumab may improve clinical outcomes and control the disease.
Recruiting1 award Phase 213 criteria
JCAR017
for Chronic Leukemia or Lymphoma
This trial tests JCAR017, a therapy using modified immune cells, in adults with hard-to-treat CLL or SLL. It aims to see if these enhanced immune cells can better fight the cancer.
Recruiting1 award Phase 1 & 2
More about William G Wierda, MD, PhD
Clinical Trial Related4 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments William G Wierda, MD, PhD has experience with
- Venetoclax
- Acalabrutinib
- Obinutuzumab
- Ibrutinib
- JCAR017 (lisocabtagene Maraleucel)
- XmAb13676
Breakdown of trials William G Wierda, MD, PhD has run
Lymphoma
Cancer
T-Lymphoblastic Leukemia/Lymphoma
Lymphoid Leukemia
Chronic Lymphocytic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does William G Wierda, MD, PhD specialize in?
William G Wierda, MD, PhD focuses on Lymphoma and Cancer. In particular, much of their work with Lymphoma has involved del(17p) positive patients, or patients who are IGHV negative.
Is William G Wierda, MD, PhD currently recruiting for clinical trials?
Yes, William G Wierda, MD, PhD is currently recruiting for 2 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that William G Wierda, MD, PhD has studied deeply?
Yes, William G Wierda, MD, PhD has studied treatments such as Venetoclax, Acalabrutinib, Obinutuzumab.
What is the best way to schedule an appointment with William G Wierda, MD, PhD?
Apply for one of the trials that William G Wierda, MD, PhD is conducting.
What is the office address of William G Wierda, MD, PhD?
The office of William G Wierda, MD, PhD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.